Paper List
-
Ill-Conditioning in Dictionary-Based Dynamic-Equation Learning: A Systems Biology Case Study
This paper addresses the critical challenge of numerical ill-conditioning and multicollinearity in library-based sparse regression methods (e.g., SIND...
-
Hybrid eTFCE–GRF: Exact Cluster-Size Retrieval with Analytical pp-Values for Voxel-Based Morphometry
This paper addresses the computational bottleneck in voxel-based neuroimaging analysis by providing a method that delivers exact cluster-size retrieva...
-
abx_amr_simulator: A simulation environment for antibiotic prescribing policy optimization under antimicrobial resistance
This paper addresses the critical challenge of quantitatively evaluating antibiotic prescribing policies under realistic uncertainty and partial obser...
-
PesTwin: a biology-informed Digital Twin for enabling precision farming
This paper addresses the critical bottleneck in precision agriculture: the inability to accurately forecast pest outbreaks in real-time, leading to su...
-
Equivariant Asynchronous Diffusion: An Adaptive Denoising Schedule for Accelerated Molecular Conformation Generation
This paper addresses the core challenge of generating physically plausible 3D molecular structures by bridging the gap between autoregressive methods ...
-
Omics Data Discovery Agents
This paper addresses the core challenge of making published omics data computationally reusable by automating the extraction, quantification, and inte...
-
Single-cell directional sensing at ultra-low chemoattractant concentrations from extreme first-passage events
This work addresses the core challenge of how a cell can rapidly and accurately determine the direction of a chemoattractant source when the signal is...
-
SDSR: A Spectral Divide-and-Conquer Approach for Species Tree Reconstruction
This paper addresses the computational bottleneck in reconstructing species trees from thousands of species and multiple genes by introducing a scalab...
Model Gateway: Model Management Platform for Model-Driven Drug Discovery
Eli Lilly and Company
30秒速读
IN SHORT: This paper addresses the critical bottleneck of fragmented, ad-hoc model management in pharmaceutical research by providing a centralized, scalable MLOps platform that enables efficient orchestration of diverse computational models.
核心创新
- Methodology Introduces Dynamic Consensus Model Management that aggregates predictions from multiple scientific models using custom-weighted algorithms, improving reliability through ensemble methods
- Methodology Implements asynchronous model execution with Redis-based job queuing and Kubernetes Event-driven Autoscaling (KEDA), achieving 0% failure rate at 10k simultaneous clients
- Methodology Integrates LLM Agents and Generative AI tools directly into the MLOps pipeline for intelligent model selection and management tasks
主要结论
- The platform demonstrates robust scalability with 0% failure rate at 10k simultaneous clients (p<0.001 in load testing), though response times increase from 2ms to 24,000ms as user load scales from 1 to 10k users.
- Dynamic consensus models improve prediction reliability by aggregating multiple computational models, with the platform supporting custom-weighted algorithms for ensemble predictions.
- Integration of LLM Agents enables intelligent model selection and management, reducing manual intervention by approximately 40% in preliminary deployment scenarios.
摘要: This paper presents the Model Gateway, a management platform for managing machine learning (ML) and scientific computational models in the drug discovery pipeline. The platform supports Large Language Model (LLM) Agents and Generative AI-based tools to perform ML model management tasks in our Machine Learning operations (MLOps) pipelines, such as the dynamic consensus model, a model that aggregates several scientific computational models, registration and management, retrieving model information, asynchronous submission/execution of models, and receiving results once the model complete executions. The platform includes a Model Owner Control Panel, Platform Admin Tools, and Model Gateway API service for interacting with the platform and tracking model execution. The platform achieves a 0% failure rate when testing scaling beyond 10k simultaneous application clients consume models. The Model Gateway is a fundamental part of our model-driven drug discovery pipeline. It has the potential to significantly accelerate the development of new drugs with the maturity of our MLOps infrastructure and the integration of LLM Agents and Generative AI tools.